Literature DB >> 25680506

Theanine prevents doxorubicin-induced acute hepatotoxicity by reducing intrinsic apoptotic response.

Katsuhito Nagai1, Ayano Oda2, Hiroki Konishi2.   

Abstract

Doxorubicin (DOX) is widely used as an antitumor agent with topoisomerase II inhibiting activity; however, its dosage and duration of administration have been strictly limited due to dose-related organ damage. The present study investigated whether theanine, an amino acid found in green tea leaves, could reduce DOX-induced acute hepatotoxicity and the apoptotic response in mice. Activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum, biomarkers of hepatic impairment, were markedly increased after the administration of 20 mg/kg DOX, whereas the degree of these elevations was significantly attenuated by 10 mg/kg theanine, which was consistent with histological hepatic images assessed by microscopic examination. The hepatic expression of Bax and Fas, representative intrinsic and extrinsic apoptotic molecules, respectively, was significantly increased by dosing with DOX. However, the elevation in the hepatic expression of Bax, but not Fas, was suppressed to control levels by theanine. The formation of cleaved caspase-3 protein in the group given DOX with theanine was significantly lower than that in the group treated with DOX alone. These results suggest that theanine can protect against acute hepatic damage induced by DOX, which is attributed to the suppression of intrinsic caspase-3-dependent apoptotic signaling.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptotic response; Biochemical modulation; Doxorubicin; Hepatotoxicity; Theanine

Mesh:

Substances:

Year:  2015        PMID: 25680506     DOI: 10.1016/j.fct.2015.02.009

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Magnesium isoglycyrrhizinate ameliorates doxorubicin-induced acute cardiac and hepatic toxicity via anti-oxidant and anti-apoptotic mechanisms in mice.

Authors:  Zhonglin Wu; Yuanyuan Zhang; Tao Song; Qiongtao Song; Ying Zhang; Xuan Zhang; Xue Han; Jianping Zhang; Li Chu
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

2.  Safety and anti-hyperglycemic efficacy of various tea types in mice.

Authors:  Manman Han; Guangshan Zhao; Yijun Wang; Dongxu Wang; Feng Sun; Jingming Ning; Xiaochun Wan; Jinsong Zhang
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

3.  Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells.

Authors:  Alaaeldin Ahmed Hamza; Mahguob Mohamed Ahmed; Hanan Mohamed Elwey; Amr Amin
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

4.  Mokko Lactone Attenuates Doxorubicin-Induced Hepatotoxicity in Rats: Emphasis on Sirt-1/FOXO1/NF-κB Axis.

Authors:  Alaa Sirwi; Rasheed A Shaik; Abdulmohsin J Alamoudi; Basma G Eid; Ahmed K Kammoun; Sabrin R M Ibrahim; Gamal A Mohamed; Hossam M Abdallah; Ashraf B Abdel-Naim
Journal:  Nutrients       Date:  2021-11-19       Impact factor: 5.717

5.  Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway.

Authors:  Xianchou Xu; Qingbo Liu; Jiahao Li; Mengjie Xiao; Ting Gao; Xiaohui Zhang; Guangping Lu; Jie Wang; Yuanfang Guo; Peinan Wen; Junlian Gu
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

6.  Acute and Subchronic Oral Toxicity of Fermented Green Tea with Aquilariae Lignum in Rodents.

Authors:  Sol Lee; Phil Hyun Song; Young Joon Lee; Sae-Kwang Ku; Chang-Hyun Song
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-10       Impact factor: 2.629

7.  Metabolic Effects of Doxorubicin on the Rat Liver Assessed With Hyperpolarized MRI and Metabolomics.

Authors:  Kerstin N Timm; Vicky Ball; Jack J Miller; Dragana Savic; James A West; Julian L Griffin; Damian J Tyler
Journal:  Front Physiol       Date:  2022-01-05       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.